Live Updates:

On | Off

  • ISIS PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2009 FY2008 FY2007 FY2006 FY2005
    Assets
    Cash and Short Term Investments 578.19 M 491.00 M 193.72 M 193.33 M 94.39 M
    Net Receivables 10.90 M 4.12 M 6.18 M 2.40 M 3.92 M
    Total Inventories 2.77 M 2.72 M 2.82 M 861,000.00 951,000.00
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses — — — — —
    Other Current Assets 4.27 M 20.55 M 4.60 M 9.61 M 6.60 M
    Current Assets Total 596.13 M 518.38 M 207.32 M 206.20 M 105.86 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 625,000.00 625,000.00 2.12 M 2.12 M 5.64 M
    Property, Plant & Equipment Net 27.34 M 17.37 M 7.13 M 7.16 M 9.13 M
    Property, Plant & Equipment Gross 63.70 M 49.81 M 38.66 M 36.05 M 34.18 M
    Accumulated Depreciation 36.36 M 32.44 M 31.53 M 28.90 M 25.05 M
    Other Assets 33.10 M 37.77 M 42.28 M 40.42 M 45.74 M
    Deferred Charges 4.74 M — — — —
    Tangible Other Assets 2.64 M 4.65 M 686,000.00 2.15 M 3.20 M
    Intangible Other Assets 30.45 M 33.12 M 36.86 M 38.27 M 42.54 M
    Total Assets 657.18 M 574.15 M 258.86 M 255.91 M 166.37 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 4.27 M 2.06 M 7.24 M 7.51 M 7.84 M
    Accrued Payroll 7.14 M 6.84 M 10.46 M 6.22 M 3.71 M
    Income Taxes Payable 7.32 M 0.00 0.00 0.00 0.00
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 88.02 M 110.09 M 40.00 M 7.12 M 10.16 M
    Current Liabilities Total 111.44 M 124.70 M 62.20 M 25.14 M 23.79 M
    Long Term Debt 136.58 M 172.44 M 162.86 M 132.82 M 139.92 M
    Provision for Risks & Charges — — — — —
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 107.10 M 172.77 M 23.55 M 44,000.00 0.00
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 0.00 0.00 0.00 0.00 0.00
    Total Liabilities 355.12 M 469.90 M 248.62 M 158.00 M 163.71 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 10.34 M 37.16 M 9.37 M 29.34 M 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 291.72 M 67.09 M 872,000.00 68.56 M 2.66 M
    Common Stock 99,000.00 97,000.00 87,000.00 82,000.00 72,000.00
    Capital Surplus 985.62 M 905.72 M 827.99 M 880.95 M 770.26 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves -72,000.00 -294,000.00 — — —
    Unappropriated (Free) Reserves 0.00 — — — —
    Retained Earnings -696.15 M -839.71 M -827.74 M -816.75 M -770.85 M
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities 2.15 M 982,000.00 538,000.00 4.28 M 3.18 M
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 657.18 M 574.15 M 258.86 M 255.91 M 166.37 M
    Common Shares Outstanding 98.85 M 97.17 M 87.24 M 82.28 M 72.20 M